| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/08/2009 | US20090012295 Amorphous Erlotinib, processes for the preparation thereof, and processes to prepare additional forms of Erlotinib |
| 01/08/2009 | US20090012290 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
| 01/08/2009 | US20090012108 Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 01/08/2009 | US20090012094 e.g. tert-butyl 2-(4-(2-(4-(2-(diethylamino)ethoxy)phenylamino)pyrimidin-5-yl)-2-fluorobenzamido)acetate; C-kit kinase receptor or stem cell factor inhibitors; asthma allergic sinusitis and rhinitis, atopic and allergic dermatitis, allergic contact rheumatoid arthritis, multiple sclerosis, lupus etc. |
| 01/08/2009 | US20090012091 Oximide derivatives and their therapeutical application |
| 01/08/2009 | US20090012070 Pesticidal heterocycles |
| 01/08/2009 | US20090012059 Dipeptidyl peptidase inhibitors |
| 01/08/2009 | US20090012055 Piperidine derivatives such as 4-{4-[3-(2-Methoxybenzyloxy)propoxy]phenyl}-3-[3-methoxy-5-(3-methoxypropoxy)benzyloxy]piperidine, suitable as renin inhibitors, used for the treatment of hypertension, heart failure, glaucoma, cardiac infarction, kidney failure or restenosis; improved pharmacokinetics |
| 01/08/2009 | US20090010860 used for protecting human hair and skin against the damaging effect of ultraviolet radiation |
| 01/08/2009 | CA2694242A1 Process for introduction of hydroxyethoxy side chain in bosentan |
| 01/08/2009 | CA2692506A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 01/08/2009 | CA2692460A1 Novel hiv reverse transcriptase inhibitors |
| 01/08/2009 | CA2690679A1 A process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates |
| 01/07/2009 | EP2011518A1 Test agent for diagnosing dyspepsia |
| 01/07/2009 | EP2010505A2 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 01/07/2009 | EP2010504A1 Quinazolin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/07/2009 | EP2010503A1 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists |
| 01/07/2009 | EP2010502A1 Pyrimidine derivatives for the treatment of amyloid-related diseases |
| 01/07/2009 | EP2010183A2 Processes for synthesizing 7-alkynyl-4-aminoquinazolines and a related intermediate |
| 01/07/2009 | EP1667966A4 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| 01/07/2009 | EP1569916B1 Substituted aralkyl derivatives |
| 01/07/2009 | EP1470113B1 Pyrimidinone viral polymerase inhibitors |
| 01/07/2009 | EP1392662B1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 01/07/2009 | CN101341134A 嘧啶衍生物 Pyrimidine derivatives |
| 01/07/2009 | CN101341133A Quinazoline derivatives, process for their preparation and their use as anti-cancer agents |
| 01/07/2009 | CN101341124A Six-membered heterocycles useful as serine protease inhibitors |
| 01/07/2009 | CN101341123A 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 01/07/2009 | CN101340959A Process for the treatment of an aqueous mixture comprising a dipolar aprotic compound |
| 01/07/2009 | CN101337944A P-38 kinase inhibitors |
| 01/07/2009 | CN101337943A Azo compound or salts thereof |
| 01/07/2009 | CN101337942A Azo compound or salts thereof |
| 01/07/2009 | CN101337941A Azo compound or salts thereof |
| 01/07/2009 | CN101337940A Nitrogen heterocyclic ring dichlorin allyl ether compounds with insecticidal activity |
| 01/07/2009 | CN100448844C Inhibitors of histone deacetylase |
| 01/06/2009 | US7473694 excellent inhibitory activity against MAPKAP-K2; inflammatory disorder, autoimmune diseases, destructive osteopathy, cancer and/or tumor growth; (4-ethoxyphenyl)(5-piperidin-3-yl-6,7-dihydro-5H-1,4,5,8a-tetraaza-s-indacen-8-yl)amine |
| 01/06/2009 | CA2421008C Substituted heterocyclic compounds for treating multidrug resistance |
| 01/06/2009 | CA2379086C 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 01/06/2009 | CA2295446C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 01/01/2009 | US20090005560 Production method of diaminopyrimidine compounds |
| 01/01/2009 | US20090005370 Isoxazole-imidazole derivatives |
| 01/01/2009 | US20090005334 Nucleic acid derivatives |
| 01/01/2009 | US20090004185 Amino-substituted quinazoline derivatives as inhibitors of beta-catenin/tcf-4 pathway and cancer treatment agents |
| 12/31/2008 | WO2009002808A2 Quinazolinone compounds and methods of use thereof |
| 12/31/2008 | WO2009002538A2 Amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional forms of erlotinib |
| 12/31/2008 | WO2009000757A1 Piperazine compounds with herbicidal action |
| 12/31/2008 | WO2009000085A1 Quinoline and quinazoline derivatives useful as modulators of gated ion channels |
| 12/31/2008 | WO2008132138A9 Derivatives of 4,6-disubstituted aminopyrimidines |
| 12/31/2008 | WO2008132138A8 Derivatives of 4,6-disubstituted aminopyrimidines |
| 12/31/2008 | WO2008128072A3 Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders |
| 12/31/2008 | WO2008053221A3 Process for preparing indol- 5 -oxy- quinazoline derivatives and intermediates |
| 12/31/2008 | WO2008021049A3 Crystalline antifungal compounds |
| 12/31/2008 | WO2008008359A3 Benzofuro-and benzothienopyryimidine modulators of the histamine h4 receptor |
| 12/31/2008 | EP2009003A1 Production method of diaminopyrimidine compounds |
| 12/31/2008 | EP2008210A1 Modulation of phosphoryl transferase activity of glutamine synthetase |
| 12/31/2008 | EP2007752A2 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor |
| 12/31/2008 | EP2007737A2 Chemical compounds |
| 12/31/2008 | EP2007736A1 Substituted quinazolines with anti-cancer activity |
| 12/31/2008 | EP2007717A1 Novel sulfonamide compounds |
| 12/31/2008 | EP1732926B1 Mitotic kinesin inhibitors |
| 12/31/2008 | EP1507775B1 Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| 12/31/2008 | EP1409707B1 Method for obtaining useful products from organisms |
| 12/31/2008 | CN101336237A Pyrimidinyl aryl urea derivatives being fgf inhibitors |
| 12/31/2008 | CN101336113A Pharmaceutical comprising PPAR agonist |
| 12/31/2008 | CN101333187A Novel PI3K enzyme inhibitors and uses thereof |
| 12/31/2008 | CN101333174A N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/31/2008 | CN100447137C P-38 kinase inhibitors |
| 12/31/2008 | CN100447136C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
| 12/31/2008 | CN100447135C 2-chloro-4,6-dimethoxy pyrimidine preparing method |
| 12/31/2008 | CN100446767C Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
| 12/31/2008 | CA2704282A1 Quinazolinone compounds and methods of use thereof |
| 12/31/2008 | CA2691932A1 Use of compounds for preparing anti-tuberculosis agents |
| 12/31/2008 | CA2686224A1 Piperazine compounds having herbicidal action |
| 12/30/2008 | US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 12/30/2008 | US7470701 e.g. 3-(4-fluorophenyl)-N-{5-[2-(methylamino)pyrimidin-4-yl]thien-2-yl}propanamide; PKB/Akt kinase inhibitor; anticarcinogenic agent; carcinoma, cancer metastases, squamous cell carcinoma, esophageal squamous cell carcinoma, oral carcinoma, cutaneous T cell lymphoma, Hodgkin's lymphoma |
| 12/30/2008 | US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 12/30/2008 | US7470699 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 12/30/2008 | US7470698 Adenosine A3 receptor modulators |
| 12/30/2008 | US7470694 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase |
| 12/30/2008 | US7470685 e.g. 1-(2-(4-(N'-(3-Methyl-benzylidene)-hydrazino)-6-morpholin-4-yl-pyrimidin-2 -yloxy)-ethyl)-1H-pyridin-2-one; control interleukin production; antiinflammatory, antidiabetic agent; interleukin IL-12 overproduction-related disorder: rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis |
| 12/30/2008 | US7470681 Pyrimidine compounds |
| 12/25/2008 | US20080319194 Process for Preparing Quinazolinone Derivatives |
| 12/25/2008 | US20080319188 Novel pyridine derivatives and pyrimidine derivatives (3) |
| 12/25/2008 | US20080318989 Pyrimidine Kinase Inhibitors |
| 12/25/2008 | US20080318985 Novel 2-Aminopyrimidinone Or 2-Aminopyridinone Derivatives and Their Use |
| 12/25/2008 | US20080318978 Hyperaldosteronism; 4-(5,6,7,8-Tetrahydroimidazo[1,5-a]phyridin-5-yl)cyclohexanecarbonitrile; 1-[3-(5,6,7,8-Tetrahydroimidazo[1,5-a]pyridin-8-yl)pyrrolidin-1-yl]ethanone |
| 12/25/2008 | US20080318976 Alpha-Hydroxy Amides as Bradykinin Antagonists or Inverse Agonists |
| 12/25/2008 | US20080318959 using 3-amino-5-ethyl-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide |
| 12/25/2008 | US20080318958 New utilities of tricyclic compounds |
| 12/25/2008 | US20080318956 Inflammatory cytokine release inhibitor |
| 12/25/2008 | US20080318940 Quinazolinone Derivatives as Vanilloid Antagonists |
| 12/25/2008 | US20080318929 Pyrimidine Derivatives Useful as Inhibitors of Pkc-Theta |
| 12/24/2008 | WO2008157575A1 Protein kinase inhibitors and methods for using thereof |
| 12/24/2008 | WO2008157537A2 Compositions and methods of use for treating or preventing lipid related disorders |
| 12/24/2008 | WO2008157500A1 Aminoquinazoline cannabinoid receptor modulators for treatment of disease |
| 12/24/2008 | WO2008156781A1 Amine salts of a crth2 antagonist |
| 12/24/2008 | WO2008156780A1 Particulates of a crth2 antagonist |
| 12/24/2008 | WO2008156573A1 Kinase inhibitors, compositions thereof, and methods of use therewith |
| 12/24/2008 | WO2008156196A1 Bipyridine compound, transition metal complex, and method for production of conjugated aromatic compound using the transition metal complex |
| 12/24/2008 | WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
| 12/24/2008 | WO2008155613A1 An improved process for preparing purine derivative |